Robert Matthew Lutz - 11 Nov 2022 Form 4 Insider Report for iBio, Inc. (IBIO)

Reporting relationship: Chief Financial & Business Officer and Principal Accounting Officer
Issuer ticker: IBIO
Reported as of: 11 Nov 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Nov 2022, 07:33:42 UTC
Prior SEC filing: 31 Aug 2022
Next SEC filing: 22 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/Robert Matthew Lutz

Key filing fact

Robert Matthew Lutz filed Form 4 for iBio, Inc. (IBIO) on 15 Nov 2022.

Key facts

This page summarizes Robert Matthew Lutz's Form 4 filing for iBio, Inc. (IBIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Nov 2022, 07:33.

Change

Previous filing in this sequence was filed on 31 Aug 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IBIO transaction

Common Stock

Award

Transaction value: $0
Shares: +100,057
Change %: +4747%
Price: $0.000000
Shares after: 102,165
Date: 11 Nov 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of 100,057 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 100,057 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 100,057 RSUs vest the earlier of: (i) July 1, 2023, or (ii) the successful achievement of the Corporation's 2023 objectives, as defined by the Board of Directors.

SEC remarks

Chief Financial & Business Officer and Principal Accounting Officer